PFIZER AND WYETH PAY OUR MILLIONS IN MEDICAID SCAM SETTLEMENT
May 1st, 2016
AMERICAN pharma company Wyeth and its parent Pfizer have agreed to pay USD784.6 million to the US federal and 34 state governments to resolve allegations that Wyeth failed to report to Medicaid administrators the lowest price it charged for two proton pump inhibitor (PPI) drugs. Under the US medicine funding system, pharma companies pay rebates to state Medicaid programmes where higher charges are made elsewhere for medicines. But regarding Protonix Oral and Protonix IV, Wyeth did not report bundled sales agreements to hospitals that effectively made these drugs ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.